Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5851114 | 0.77 | ADORA3 (0.35) | ADORA3PDK2 | |
| SCHEMBL3124906 | 0.74 | ADORA3 (0.33) | ADORA3PDK2 | |
| SCHEMBL5486167 | 0.74 | HTR5A (0.33) | ADORA3PDK2 | |
| SCHEMBL14575103 | 0.74 | ADORA3 (0.33) | ADORA3PDK2 | |
| SCHEMBL28499297 | 0.72 | ADORA3 (0.33) | ADORA3 | |
| SCHEMBL9620915 | 0.71 | — | — | |
| SCHEMBL28806304 | 0.71 | P2RX1 (0.35) | ADORA3 | |
| SCHEMBL31738480 | 0.69 | — | — | |
| SCHEMBL28330586 | 0.69 | — | — | |
| SCHEMBL30876182 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1235927-B1 | NOVEL ENZYMATIC SUBSTRATES FOR DETECTING PSEUDOMONAS AERUGINOSA | BIOMERIEUX SA (FR) | 2006-03-08 | — | — | EP | claimed |
| EP-1621530-A1 | Methods, compositions et enzyme substrates for the detection of Pseudomonas Aeruginosa | BIOMERIEUX SA (FR) | 2006-02-01 | — | — | EP | claimed |
| US-6905841-B2 | Enzymatic substrates for detecting Pseudomonas aeruginas | BIOMERIEUX S.A. (FR) | 2005-06-14 | — | — | US | claimed |
| CN-1408026-A | Novel enzyme substrates for the detection of Pseudomonas aeruginosa, compositions containing them, and methods for detecting this species | BIOMERIEUX SA (FR) | 2003-04-02 | — | — | CN | claimed |
| US-20030044877-A1 | Novel enzymatic substrates for detecting pseudomonas aeruginosa, compositions containing same and method for detecting said species | BIOMERIEUX S.A. (FR) | 2003-03-06 | — | — | US | claimed |
| EP-1235927-A2 | NOVEL ENZYMATIC SUBSTRATES FOR DETECTING PSEUDOMONAS AERUGINOSA | Biomerieux S.A. (FR) | 2002-09-04 | — | — | EP | claimed |
| WO-2001042491-A2 | NOVEL ENZYMATIC SUBSTRATES FOR DETECTING PSEUDOMONAS AERUGINOSA | BIOMERIEUX S.A. (FR) | 2001-06-14 | — | — | WO | claimed |
| CN-101142184-A | Sulfonamide peri-substituted bicyclics for occlusive artery disease | DECODE GENETICS INC (IS) | 2008-03-12 | — | — | CN | disclosed |
| EP-1235927-B1 | NOVEL ENZYMATIC SUBSTRATES FOR DETECTING PSEUDOMONAS AERUGINOSA | BIOMERIEUX SA (FR) | 2006-03-08 | — | — | EP | disclosed |
| EP-1621530-A1 | Methods, compositions et enzyme substrates for the detection of Pseudomonas Aeruginosa | BIOMERIEUX SA (FR) | 2006-02-01 | — | — | EP | disclosed |
| US-6905841-B2 | Enzymatic substrates for detecting Pseudomonas aeruginas | BIOMERIEUX S.A. (FR) | 2005-06-14 | — | — | US | disclosed |
| CN-1408026-A | Novel enzyme substrates for the detection of Pseudomonas aeruginosa, compositions containing them, and methods for detecting this species | BIOMERIEUX SA (FR) | 2003-04-02 | — | — | CN | disclosed |
| US-20030044877-A1 | Novel enzymatic substrates for detecting pseudomonas aeruginosa, compositions containing same and method for detecting said species | BIOMERIEUX S.A. (FR) | 2003-03-06 | — | — | US | disclosed |
| EP-1235927-A2 | NOVEL ENZYMATIC SUBSTRATES FOR DETECTING PSEUDOMONAS AERUGINOSA | Biomerieux S.A. (FR) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001042491-A2 | NOVEL ENZYMATIC SUBSTRATES FOR DETECTING PSEUDOMONAS AERUGINOSA | BIOMERIEUX S.A. (FR) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030044877-A1 | Novel enzymatic substrates for detecting pseudomonas aeruginosa, compositions containing same and method for detecting said species | PEPD, ENPEP, ANPEP | ADORA3 1767/4885PDK2 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.